Anti-kir combination treatments and methods
作者： Peter Andreas Nicolai Reumert Wagtmann , Joakim Glamann , Francois Romagné
DOI:
关键词: Human immunodeficiency virus (HIV) 、 Immunology 、 Lung cancer 、 Medicine 、 Viral infection 、 Virology 、 Antibody
摘要: Compositions comprising anti-KIR antibodies and one or more secondary anti-cancer agents anti-viral methods of using such combinations (as combination compositions in separate administration protocols) the treatment cancers (e.g., lung cancer) viral infection HIV HCV infection) are provided.
lens.org 参考文章(163)
Vincent R. Zurawski, Paul H. Black, Edgar Haber, Continuously Proliferating Human Cell Lines Synthesizing Antibody of Predetermined Specificity Monoclonal Antibodies. pp. 19- 33 ,(1980) , 10.1007/978-1-4615-7505-4_2
Ira Pastan, Ulrich Brinkmann, Method for detecting cancer cells ,(1999)
Imre Kovesdi, Paul D. Kessler, Angiopioetin related factors ,(2002)
Seiga Itoh, Hiromasa Miyaji, Novel human interleukin 2 polypeptide derivative ,(1986)
G. M. Grass, J. R. Robinson, Sustained- and controlled-release drug delivery systems Drugs and the pharmaceutical sciences. ,vol. 40, pp. 635- 671 ,(1978)
Jack E. Bridges, Microwave method and system to detect and locate cancers in heterogenous tissues ,(1996)
William O. Foye, Cancer chemotherapeutic agents American Chemical Society. ,(1995)
Olwyn M. R. Westwood, Frank C. Hay, Epitope mapping : a practical approach Oxford University Press. ,(2000)
Mike R Sather, Cancer Chemotherapeutic Agents: Handbook of Clinical Data ,(1979)
Sonia Proulx, Carmen Parent, Campbell Lockhart, Yves Fradet, Immunological composition for detection of bladder cancer and method of using same ,(1997)